Skip to main content

Table 4 Standardised prevalence of chronic diseases in patients with COPD

From: Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study

EDC Observed prevalence Expected prevalence SPR* Lower CI Upper CI
% COPD % COPD
Congestive heart failure 8.03 3.34 2.41 1.88 2.93
Chronic liver disease 4.99 2.63 1.89 1.37 2.42
Asthma 5.83 3.36 1.73 1.29 2.18
Generalised atherosclerosis 10.47 6.25 1.67 1.35 1.99
Osteoporosis 6.98 4.91 1.42 1.09 1.75
Ischaemic heart disease 8.45 6.00 1.41 1.11 1.71
Schizophrenia 1.15 0.85 1.35 0.57 2.12
Thyroid disease 14.21 11.06 1.28 1.07 1.50
Chronic renal failure 6.34 4.96 1.28 0.96 1.59
Anxiety/Depression 20.20 15.86 1.27 1.10 1.45
Cardiac valve disease 2.21 1.76 1.25 0.73 1.77
Cardiac arrhythmia 15.81 12.70 1.25 1.05 1.44
Obesity 25.32 20.49 1.24 1.08 1.39
Chronic skin ulcer 2.37 1.96 1.20 0.72 1.69
Glaucoma 5.31 4.51 1.18 0.86 1.46
Cerebrovascular disease 7.49 6.48 1.16 0.89 1.42
Diabetes mellitus 20.77 18.24 1.14 0.98 1.29
Degenerative joint disease 5.67 5.11 1.11 0.82 1.40
Malignant neoplasms 12.90 11.63 1.11 0.92 1.30
Disorders of lipid metabolism 34.44 31.32 1.10 0.98 1.22
Arterial hypertension 51.98 48.14 1.08 0.99 1.17
Deafness, hearing loss 8.19 7.87 1.04 0.82 1.27
Parkinson’s disease 1.66 1.71 0.97 0.50 1.44
Benign prostatic hypertrophy 15.81 16.41 0.96 0.81 1.11
Dementias 1.92 2.56 0.75 0.41 1.08
  1. EDC: expanded diagnosis cluster.
  2. (*) Standardised prevalence ratio.